Sami-Sabinsa Group

Sami-Sabinsa Group Sami-Sabinsa Group Limited (formerly Sami Labs Ltd), a pioneer and global leader in health science,

Sami-Sabinsa Group Limited (formerly Sami Labs Ltd), a pioneer and global leader in health science, is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, probiotics and enzymes. Founded in 1988 by Dr. Muhammed Majeed, an internationally acclaimed scientist turned entrepreneur in the field of Evidence Based Medicine, the Group ha

s independent research divisions including Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulations R&D all of which coordinate in a synergistic work model to create products meeting international standards. A team of over 120 research scientists work tirelessly to discover and develop standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe. Demonstrating its commitment to sustainable development, Sami-Sabinsa Group, under the visionary leadership of Dr. Majeed, pioneered the contract farming model deploying close to 20,000 acres of land in India. The Group has a sizeable patent portfolio comprising over 383 granted patents and 300 pending patent applications worldwide. Sami-Sabinsa Group manufactures its products as per global standards at its seven state-of-the-art manufacturing facilities located in Bengaluru, Hyderabad and Utah (USA). Our Bengaluru and Hyderabad facilities are FSSC 22000, FSSAI and USP GMP certified and our US facility is NSF GMP certified. The Sami-Sabinsa group is a global organization with a presence in 13 countries that include the USA (New Jersey & Utah), Australia, Canada, China, Germany, India, Japan, Poland, South Africa, South Korea, Brazil, UAE, and Vietnam.

22/05/2026

We’re delighted to share the recent featured article on 𝘕𝘶𝘵𝘳𝘢𝘐𝘯𝘨𝘳𝘦𝘥𝘪𝘦𝘯𝘵𝘴.𝘤𝘰𝘮, highlighting Sabinsa’s next-generation curcumin innovation, Curcumin C3 Reduct® (May 2026).
This immersive feature, titled ‘𝐍𝐞𝐰 𝐜𝐮𝐫𝐜𝐮𝐦𝐢𝐧 𝐡𝐨𝐫𝐢𝐳𝐨𝐧𝐬: 𝐔𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐟𝐨𝐫𝐦𝐚𝐭𝐬,’ explores how Curcumin C3 Reduct® addresses long-standing formulation challenges associated with traditional curcumin, including poor solubility, instability, taste, yellow staining, and limited formulation flexibility.

Building on the strong scientific and clinical legacy of Curcumin C3 Complex®, Curcumin C3 Reduct® represents the next evolution in curcumin innovation, enabling greater formulation flexibility across modern delivery formats.

𝐊𝐞𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐂𝐮𝐫𝐜𝐮𝐦𝐢𝐧 𝐂𝟑 𝐑𝐞𝐝𝐮𝐜𝐭®:
● Delivers curcuminoids in their active metabolite form (tetrahydrocurcuminoids – THCs)
● Improves stability and supports enhanced bioavailability potential
● Colorless nature eliminates staining and enables clean-format applications
● Expands usage across beverages, gummies, chewables, oral care, and more

Commenting on this innovation, Dr. Shaheen Majeed (D.Litt.), MBA, Global CEO and MD, Sabinsa, said, "𝘖𝘶𝘳 𝘳𝘰𝘭𝘦 𝘪𝘴 𝘵𝘰 𝘩𝘦𝘭𝘱 𝘣𝘳𝘢𝘯𝘥𝘴 𝘮𝘰𝘷𝘦 𝘧𝘳𝘰𝘮 𝘤𝘰𝘯𝘤𝘦𝘱𝘵 𝘵𝘰 𝘢 𝘧𝘪𝘯𝘪𝘴𝘩𝘦𝘥 𝘱𝘳𝘰𝘥𝘶𝘤𝘵 𝘢𝘴 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵𝘭𝘺 𝘢𝘯𝘥 𝘤𝘰𝘯𝘧𝘪𝘥𝘦𝘯𝘵𝘭𝘺 𝘢𝘴 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦."

Adding to this, Dr. Umar Jan, PhD, MBA, President - European Operations, Sabinsa, said, "𝘛𝘩𝘦 𝘤𝘰𝘭𝘰𝘳𝘭𝘦𝘴𝘴, 𝘵𝘢𝘴𝘵𝘦-𝘯𝘦𝘶𝘵𝘳𝘢𝘭, 𝘱𝘏-𝘴𝘵𝘢𝘣𝘭𝘦 𝘱𝘳𝘰𝘧𝘪𝘭𝘦 𝘰𝘧 𝘊𝘶𝘳𝘤𝘶𝘮𝘪𝘯 𝘊3 𝘙𝘦𝘥𝘶𝘤𝘵® (𝘊3 𝘙𝘦𝘥𝘶𝘤𝘵) 𝘪𝘴 𝘸𝘩𝘢𝘵, 𝘯𝘰𝘸 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘧𝘪𝘳𝘴𝘵 𝘵𝘪𝘮𝘦, 𝘮𝘢𝘬𝘦𝘴 𝘵𝘩𝘦𝘴𝘦 𝘤𝘢𝘵𝘦𝘨𝘰𝘳𝘪𝘦𝘴 𝘨𝘦𝘯𝘶𝘪𝘯𝘦𝘭𝘺 𝘢𝘤𝘤𝘦𝘴𝘴𝘪𝘣𝘭𝘦 𝘵𝘰 𝘧𝘰𝘳𝘮𝘶𝘭𝘢𝘵𝘰𝘳𝘴 𝘴𝘦𝘦𝘬𝘪𝘯𝘨 𝘵𝘰 𝘣𝘳𝘪𝘯𝘨 𝘤𝘶𝘳𝘤𝘶𝘮𝘪𝘯’𝘴 𝘣𝘦𝘯𝘦𝘧𝘪𝘵𝘴 𝘵𝘰 𝘢 𝘣𝘳𝘰𝘢𝘥𝘦𝘳 𝘤𝘰𝘯𝘴𝘶𝘮𝘦𝘳 𝘢𝘶𝘥𝘪𝘦𝘯𝘤𝘦."
As demand grows for science-backed, application-ready ingredients, Sabinsa remains committed to advancing curcumin innovation through research-driven development.
Read more... https://shorturl.at/tEX0q

22/05/2026
20/05/2026

Join us at the 𝐍𝐞𝐰 𝐘𝐨𝐫𝐤 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 𝐨𝐟 𝐂𝐨𝐬𝐦𝐞𝐭𝐢𝐜 𝐂𝐡𝐞𝐦𝐢𝐬𝐭𝐬 (𝐍𝐘𝐒𝐂𝐂) 𝐒𝐮𝐩𝐩𝐥𝐢𝐞𝐫𝐬’ 𝐃𝐚𝐲 𝟐𝟎𝟐𝟔—a leading event for cosmetic science, formulation, and ingredient innovation.

📍 Booth #527
📅 May 19–20, 2026
📌 Javits Convention Center, New York City
✨ Launching our latest cosmetic ingredient: 𝐌𝐚𝐧𝐠𝐢𝐨𝐩𝐡𝐞𝐥𝐢𝐧®

Also featuring our science-backed botanical portfolio:
𝐁𝐚𝐛𝐜𝐡𝐢𝐨𝐥™ | 𝐂𝐨𝐜𝐨𝐜𝐢𝐧® | 𝐏𝐫𝐨𝐬𝐜𝐚𝐥𝐩𝐢𝐧® | 𝐩𝐓𝐞𝐫𝐨𝐖𝐡𝐢𝐭𝐞® | 𝐒𝐚𝐛𝐞𝐫𝐫𝐲® | 𝐒𝐚𝐛𝐢𝐖𝐡𝐢𝐭𝐞®

We look forward to connecting with formulators, brands, and innovators to collaborate in shaping the future of science-led beauty.

Register here: https://shorturl.at/K0oV8

19/05/2026

We are thrilled to announce that Sabinsa will be exhibiting at the New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day 2026, one of the world’s leading events for cosmetic chemistry, formulation science, and ingredient innovation.
Join us as we showcase our science-backed portfolio of botanical actives to support formulators across skincare, haircare, and beauty-from-within categories.

📍 Booth: #527
📅 May 19-20, 2026
📌 Javits Convention Center, New York City

Highlights:
Sabinsa’s newest cosmetic ingredient launch: Mangiophelin®
• Designed to help improve multiple visible signs of skin aging
• Suitable for topical skincare and ingestible beauty applications
• Supports the fast-growing nutricosmetics space

Featured Ingredients:
Explore our portfolio of science-backed ingredients:
Babchiol™ | Cococin® | Proscalpin® | pTeroWhite® | Saberry® | SabiWhite®

We look forward to connecting with formulators, brand leaders, and industry innovators to discuss new opportunities in science-led beauty and sustainable ingredient solutions.
Register here: https://shorturl.at/K0oV8.

18/05/2026
13/05/2026

Curcumin is one of the most researched botanicals in the nutraceutical space.

Yet, its effectiveness depends on a critical factor -bioavailability.

Without proper absorption, even the most potent ingredients may not deliver desired results. That’s where innovation plays a key role. Sami-Sabinsa’s scientifically validated approaches are designed to enhance bioavailability and support optimal performance.

Discover the science behind better curcumin efficacy. Reach out to us: https://sami-sabinsagroup.com/contact-us

13/05/2026

At SupplySide Connect New Jersey 2026 (April 14–15, 2026), Sabinsa’s VP of Sales, Mr. Jan Obirek, shared the company’s evolving approach to customer partnerships in an exclusive 𝐍𝐮𝐭𝐫𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 𝐖𝐨𝐫𝐥𝐝 𝐕𝐢𝐝𝐞𝐨𝐁𝐢𝐭𝐞𝐬 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰, released on April 29, 2026.

In the interview, titled ‘𝘚𝘢𝘣𝘪𝘯𝘴𝘢 𝘓𝘦𝘢𝘯𝘴 𝘰𝘯 𝘚𝘤𝘪𝘦𝘯𝘤𝘦, 𝘔𝘢𝘯𝘶𝘧𝘢𝘤𝘵𝘶𝘳𝘪𝘯𝘨, 𝘢𝘯𝘥 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘵𝘰 𝘋𝘦𝘦𝘱𝘦𝘯 𝘊𝘶𝘴𝘵𝘰𝘮𝘦𝘳 𝘗𝘢𝘳𝘵𝘯𝘦𝘳𝘴𝘩𝘪𝘱𝘴,’ he highlights the industry’s shift from traditional supplier roles to strategic, value-driven partnerships.

𝐊𝐞𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧:

• Expanding beyond raw materials to science-backed ingredients, formulation expertise, and turnkey solutions.
• A customer-first approach driven by market trends and insights is preferred over a transactional approach.
• Delivering market-ready products through custom formulations, contract manufacturing, and clinical collaborations.
• Positioning Sabinsa as a one-stop solutions provider across the product lifecycle.

Speaking on Sabinsa’s role as a stakeholder in its customers’ enterprise, Mr. Jan said:

“It became very obvious to us that we can do that by tapping into three basics—what I call 'pillars of Sabinsa' these days—that is, our extensive scientific knowledge & database, our incredibly diverse portfolio of ingredients, and our state-of-the-art contract manufacturing facilities.”

Watch the full interview here... https://shorturl.at/t0qbQ

Sami-Sabinsa Group marked its presence as the 𝐒𝐢𝐥𝐯𝐞𝐫 𝐒𝐩𝐨𝐧𝐬𝐨𝐫 at the 𝐂𝐈𝐈 𝐖𝐨𝐫𝐥𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧, 𝐃𝐞𝐬𝐢𝐠𝐧 & 𝐈𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐏𝐫𝐨𝐩𝐞𝐫𝐭𝐲...
11/05/2026

Sami-Sabinsa Group marked its presence as the 𝐒𝐢𝐥𝐯𝐞𝐫 𝐒𝐩𝐨𝐧𝐬𝐨𝐫 at the 𝐂𝐈𝐈 𝐖𝐨𝐫𝐥𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧, 𝐃𝐞𝐬𝐢𝐠𝐧 & 𝐈𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐏𝐫𝐨𝐩𝐞𝐫𝐭𝐲 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝟐𝟎𝟐𝟔, held on 29 April 2026 in New Delhi.

The conference, themed ‘𝘋𝘦𝘴𝘪𝘨𝘯 & 𝘐𝘗: 𝘗𝘰𝘸𝘦𝘳𝘪𝘯𝘨 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘌𝘤𝘰𝘯𝘰𝘮𝘪𝘤 𝘎𝘳𝘰𝘸𝘵𝘩,’ served as a dynamic platform for meaningful dialogue, knowledge exchange, and collaboration among key stakeholders across industry, academia, and government.

Mr. Krishnamani Jayaraman, Director – Global IP Operations and Technology Transfer, represented the Group as a key speaker in the panel discussion on ‘𝘐𝘗 𝘝𝘢𝘭𝘶𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘊𝘰𝘮𝘮𝘦𝘳𝘤𝘪𝘢𝘭𝘪𝘴𝘢𝘵𝘪𝘰𝘯: 𝘎𝘭𝘰𝘣𝘢𝘭 𝘛𝘳𝘦𝘯𝘥𝘴 𝘢𝘯𝘥 𝘗𝘳𝘢𝘤𝘵𝘪𝘤𝘦𝘴.’

At Sami-Sabinsa Group, we value this partnership and remain committed to fostering IP-driven innovation, design excellence, and a strong intellectual property ecosystem.

08/05/2026

We are delighted to share that Sabinsa was a 𝐒𝐢𝐥𝐯𝐞𝐫 𝐒𝐩𝐨𝐧𝐬𝐨𝐫 at the 𝟐𝟒𝐭𝐡 𝐀𝐧𝐧𝐮𝐚𝐥 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐨𝐧 𝐭𝐡𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐨𝐟 𝐁𝐨𝐭𝐚𝐧𝐢𝐜𝐚𝐥𝐬 (𝐈𝐂𝐒𝐁) 𝟐𝟎𝟐𝟔, held from April 20–23, 2026, at the Oxford Conference Center, 102 Ed Perry Boulevard, Oxford, MS, USA.

ICSB 2026 brought together global experts to advance botanical science. Key discussions covered:
• Plant material quality and authentication
• Botanical safety and toxicology
• Fragrance and cosmetic regulations
• Advances in botanical drug discovery
• In silico approaches to ingredient innovation

Sabinsa was represented by Dr. Alphons Philips Ph.D MBA, Director of Scientific Affairs, who contributed to insightful scientific discussions and collaborative exchange at the event.

We thank the organizers and global participants for fostering an engaging and insightful forum on the future of botanical science.

05/05/2026

We're thrilled to share that Sabinsa China will be participating in 𝐓𝐎𝐏𝐒 (𝐓𝐡𝐞 𝐎𝐧𝐞 𝐏𝐞𝐭 𝐒𝐡𝐨𝐰) 𝟐𝟎𝟐𝟔—one of the fastest-growing pet industry exhibitions in China.

This dynamic event blends B2B trade opportunities with B2C consumer engagement, bringing together global brands, buyers, and passionate pet owners under one roof.

📍 𝐁𝐨𝐨𝐭𝐡: 8E4-41
📅 𝐃𝐚𝐭𝐞𝐬: May 7–10, 2026
📌 𝐕𝐞𝐧𝐮𝐞: National Exhibition and Convention Center, Shanghai, China

This 6th edition of the expo, themed '𝘗𝘈𝘞𝘚𝘪𝘣𝘪𝘭𝘪𝘵𝘺: 𝘍𝘶𝘳 𝘗𝘰𝘸𝘦𝘳,' spans an impressive 100,000 sqm and features:

• 1,200+ exhibitors
• Over thousands of global pet brands
• Innovations across pet food, care, and smart solutions

At our booth, we’ll be showcasing our science-backed ingredient portfolio, including: Curcumin C3 Complex® | BioPerine® | Digezyme® | LactoSpore®

Click here to register: https://shorturl.at/dal2M

We look forward to connecting with you in Shanghai!

We are thrilled to announce that Sami-Sabinsa Group will be the Session Lead Partner at the 𝐀𝐒𝐒𝐎𝐂𝐇𝐀𝐌 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐏 𝐂𝐨𝐧𝐜𝐥𝐚𝐯𝐞 ...
05/05/2026

We are thrilled to announce that Sami-Sabinsa Group will be the Session Lead Partner at the 𝐀𝐒𝐒𝐎𝐂𝐇𝐀𝐌 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐏 𝐂𝐨𝐧𝐜𝐥𝐚𝐯𝐞 (𝐀𝐆𝐈𝐏𝐂) 𝟐𝟎𝟐𝟔, themed ‘𝘙𝘦𝘪𝘮𝘢𝘨𝘪𝘯𝘪𝘯𝘨 𝘐𝘯𝘥𝘪𝘢’𝘴 𝘐𝘗 𝘍𝘶𝘵𝘶𝘳𝘦: 𝘛𝘩𝘦 𝘕𝘦𝘹𝘵 𝘓𝘦𝘢𝘱 𝘵𝘰 𝘎𝘭𝘰𝘣𝘢𝘭 𝘓𝘦𝘢𝘥𝘦𝘳𝘴𝘩𝘪𝘱,’ scheduled for 6 May 2026 at Hotel The Lalit, New Delhi.

AGIPC 2026 is a premier platform bringing together policymakers, industry leaders, legal experts, innovators, and global stakeholders to exchange insights, best practices, and forward-looking strategies shaping the future of intellectual property in India and beyond.

Sami-Sabinsa Group will be represented by Mr. Krishnamani Jayaraman, Director – Global IP Operations and Technology Transfer, who will deliver the keynote address.

At Sami-Sabinsa Group, we remain committed to innovation, IP excellence, and global collaboration. We look forward to contributing to meaningful dialogue and supporting India’s journey toward a stronger global IP ecosystem.

Register here: https://shorturl.at/Kud86

Address

19/1 & 19/2 Ⅰ Main, Ⅱ Phase, Peenya Industrial Area
Bangalore
560058

Alerts

Be the first to know and let us send you an email when Sami-Sabinsa Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Sami-Sabinsa Group:

Share